Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Kintara Therapeutics ( (KTRA) ) has provided an announcement.
Kintara Therapeutics, Inc. is urging stockholders to vote on a crucial merger with TuHURA Biosciences, emphasizing the vote’s significance for the company’s future in developing cancer therapies. The vote, needed to approve the merger, is set to take place at a Special Meeting of Stockholders on September 20, 2024. Stockholders are encouraged to vote by September 19. Kintara’s CEO highlights the merger’s potential to combine oncology assets and technologies, backed by substantial financing, to advance their pipeline and combat solid tumor cancers.
See more data about KTRA stock on TipRanks’ Stock Analysis page.